Other Top Large Cap Biotech Stocks
We can actually go through this exercise for a handful of other biotech marvels. Revenue is booming, pipelines are rich, stock prices are crushed. Below I quickly posted the revenue charts for a few more popular large cap biotech stocks and the sector.
Of course, further analysis is needed than a few charts, and that’s what we do at CML Pro — get into the guts of how these companies make money. But just a taste from Gilead and Celgene above, and then a smattering of other charts below for the other biotech marvels, and we can see that the focus on selling biotechs has created a wonderful opportunity.
Here are some revenue charts to breeze through:
Amgen (AMGN)
Biogen (BIIB)
Regeneron (REGN)
Taking a more holistic approach: Here are the biotechs growing revenue the fastest over the last year ranked in one chart:
Thanks for reading.
More from Ophir: “Facebook, Apple, And The Best Tech Companies In The World“
Read more from Ophir on CMLviz.com.
Twitter: @OphirGottlieb
Author has positions in mentioned securities at the time of publication. Any opinions expressed herein are solely those of the author, and do not in any way represent the views or opinions of any other person or entity.
